Your cart is currently empty!
Amyloidosis is a condition characterized by the abnormal aggregation of proteins or their fragments into β-pleated linear sheets. These insoluble fibrils lead to cellular damage and apoptosis. Amyloid deposits can be visualized using various staining techniques.
Type | Fibril Protein | Description |
---|---|---|
Systemic | ||
Primary Amyloidosis | AL (from Ig light chains) | Seen in plasma cell disorders (e.g., multiple myeloma). |
Secondary Amyloidosis | Serum Amyloid A (AA) | Associated with chronic inflammatory conditions (e.g., rheumatoid arthritis, IBD). |
Dialysis-related Amyloidosis | β2-microglobulin | Occurs in patients with ESRD and/or on long-term dialysis. |
Localized | ||
Alzheimer Disease | β-amyloid protein | Derived from amyloid precursor protein (APP). |
Type 2 Diabetes Mellitus | Islet amyloid polypeptide (IAPP) | Caused by amylin deposition in pancreatic islets. |
Medullary Thyroid Cancer | Calcitonin | Associated with calcitonin deposition. |
Isolated Atrial Amyloidosis | ANP | Common with aging; increases risk of atrial fibrillation. |
Systemic Senile Amyloidosis | Normal (wild-type) transthyretin (TTR) | Predominantly affects cardiac ventricles; cardiac dysfunction is more gradual than in AL amyloidosis. |
Hereditary | ||
Familial Amyloid Cardiomyopathy | Mutated transthyretin (ATTR) | Causes ventricular endomyocardium deposition, leading to restrictive cardiomyopathy and arrhythmias. 5% of African Americans carry a mutant allele. |
Familial Amyloid Polyneuropathies | Mutated transthyretin (ATTR) | Results from a transthyretin gene mutation. |